IFIT1, IFIT2, IFIT3, and IFIT5 are overexpressed in acute myeloid leukemia (AML) patients, with higher levels of IFIT2, IFIT3, and IFIT5 predicting poor prognosis 51. This evidence concerns the gene IFIT5 and acute myeloid leukemia.